AU2003281109A1 - Method for screening ebna-1 inhibitors - Google Patents

Method for screening ebna-1 inhibitors

Info

Publication number
AU2003281109A1
AU2003281109A1 AU2003281109A AU2003281109A AU2003281109A1 AU 2003281109 A1 AU2003281109 A1 AU 2003281109A1 AU 2003281109 A AU2003281109 A AU 2003281109A AU 2003281109 A AU2003281109 A AU 2003281109A AU 2003281109 A1 AU2003281109 A1 AU 2003281109A1
Authority
AU
Australia
Prior art keywords
ebna
inhibitors
screening
screening ebna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003281109A
Inventor
Sayuri Itou
Kazuo Yanagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU2003281109A1 publication Critical patent/AU2003281109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
AU2003281109A 2002-07-15 2003-07-15 Method for screening ebna-1 inhibitors Abandoned AU2003281109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39561902P 2002-07-15 2002-07-15
US60/395,619 2002-07-15
PCT/JP2003/008972 WO2004008152A1 (en) 2002-07-15 2003-07-15 Method for screening ebna-1 inhibitors

Publications (1)

Publication Number Publication Date
AU2003281109A1 true AU2003281109A1 (en) 2004-02-02

Family

ID=30115901

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003281109A Abandoned AU2003281109A1 (en) 2002-07-15 2003-07-15 Method for screening ebna-1 inhibitors

Country Status (2)

Country Link
AU (1) AU2003281109A1 (en)
WO (1) WO2004008152A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10137115B2 (en) * 2016-04-26 2018-11-27 Hong Kong Baptist University Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging
CN116516069B (en) * 2023-05-10 2024-03-22 武汉大学 RPA kit for rapidly detecting Epstein-Barr virus in cells

Also Published As

Publication number Publication date
WO2004008152A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003218039A1 (en) Method for reduced methanation
AU2003300832A1 (en) NF-KappaB INHIBITORS
AU2003280568A1 (en) Method for clarifying soil
AU2003269751A1 (en) Immobilization method
AU2003249683A1 (en) Nf-:b inhibitors
AU2003297829A1 (en) Method for dynamic frequency selection
AU2003249232A1 (en) Method for managing returns
AU2003258070A1 (en) Electrodionization method
AU2003277663A1 (en) Screening method
AU2003237573A1 (en) Method for wagering
AU2003242340A1 (en) Novel screening method
AU2003224941A1 (en) NF-KappaB INHIBITORS
AU2003261957A1 (en) Method for separating substances
AU2003281109A1 (en) Method for screening ebna-1 inhibitors
AU2003253813A1 (en) Method for colpoplasty
AU2003227268A1 (en) Novel screening method
AU2003296117A1 (en) Method and apparatus for crystallization
AU2002952966A0 (en) Screening apparatus
AU2003245722A1 (en) Method for screening for kinase inhibitors
AU2003278535A1 (en) Histoscreen method
AU2003276185A1 (en) Method for suppressing vibrations
AU2003242342A1 (en) Novel screening method
AU2003248720A1 (en) Method for scale removal
AU2003217008A1 (en) Screening method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase